A randomized, double-blind, parallel-arm, placebo- and comparator- controlled trial of the efficacy and safety of multiple doses of immediate-release (IR) CG5503 [tapentadol] for postoperative pain following abdominal hysterectomy.

Trial Profile

A randomized, double-blind, parallel-arm, placebo- and comparator- controlled trial of the efficacy and safety of multiple doses of immediate-release (IR) CG5503 [tapentadol] for postoperative pain following abdominal hysterectomy.

Completed
Phase of Trial: Phase III

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Tapentadol (Primary) ; Morphine
  • Indications Postoperative pain
  • Focus Registrational; Therapeutic Use
  • Sponsors Grunenthal
  • Most Recent Events

    • 02 Feb 2010 Actual end date (Apr 2008) and actual number of patients (854) added as reported by ClinicalTrials.gov.
    • 02 Feb 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 23 Jul 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top